| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.0093 | 1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |